Philip S. Low - Publications

Affiliations: 
Chemistry Purdue University, West Lafayette, IN, United States 
Area:
ligand-targeted imaging and therapeutic agents for the diagnosis and treatment of important human diseases
Website:
http://www.chem.purdue.edu/people/faculty/faculty.asp?itemID=44

312 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Kennedy GT, Azari FS, Bernstein E, Nadeem B, Chang A, Segil A, Carlin S, Sullivan NT, Encarnado E, Desphande C, Kularatne S, Gagare P, Thomas M, Kucharczuk JC, Christien G, ... ... Low PS, et al. Targeted detection of cancer at the cellular level during biopsy by near-infrared confocal laser endomicroscopy. Nature Communications. 13: 2711. PMID 35581212 DOI: 10.1038/s41467-022-30265-z  0.793
2022 Herr SA, Gardeen SS, Low PS, Shi R. Targeted delivery of acrolein scavenger hydralazine in spinal cord injury using folate-linker-drug conjugation. Free Radical Biology & Medicine. 184: 66-73. PMID 35398493 DOI: 10.1016/j.freeradbiomed.2022.04.003  0.765
2021 Venkatesh C, Shen J, Putt KS, Low PS. Evaluation of the reducing potential of PSMA-containing endosomes by FRET imaging. Cancer Drug Resistance (Alhambra, Calif.). 4: 223-232. PMID 35582012 DOI: 10.20517/cdr.2020.84  0.649
2021 Lu YJ, Wheeler LW, Chu H, Kleindl PJ, Pugh M, You F, Rao S, Garcia G, Wu HY, da Cunha AP, Johnson R, Westrick E, Cross V, Lloyd A, Dircksen C, ... ... Low PS, et al. Targeting folate receptor beta on monocytes/macrophages renders rapid inflammation resolution independent of root causes. Cell Reports. Medicine. 2: 100422. PMID 34755134 DOI: 10.1016/j.xcrm.2021.100422  0.607
2021 Venkatesh C, Doorneweerd DD, Xia W, Putt KS, Low PS. Folate-targeted verrucarin A reduces the number of activated macrophages in a mouse model of acute peritonitis. Bioorganic & Medicinal Chemistry Letters. 128091. PMID 33964441 DOI: 10.1016/j.bmcl.2021.128091  0.621
2021 Elo P, Li XG, Liljenbäck H, Gardberg M, Moisio O, Miner M, Virta J, Saraste A, Srinivasarao M, Pugh M, Low PS, Knuuti J, Jalkanen S, Airas L, Lu YJ, et al. Efficacy and tolerability of folate-aminopterin therapy in a rat focal model of multiple sclerosis. Journal of Neuroinflammation. 18: 30. PMID 33472663 DOI: 10.1186/s12974-021-02073-7  0.407
2020 Cresswell GM, Wang B, Kischuk EM, Broman MM, Alfar RA, Vickman RE, Dimitrov DS, Kularatne SA, Sundaram CP, Singhal S, Eruslanov EB, Crist SA, Elzey BD, Ratliff TL, Low PS. Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells that Can Be Reprogrammed with Folate-Targeted Drugs. Cancer Research. PMID 33203700 DOI: 10.1158/0008-5472.CAN-20-1414  0.806
2020 Kodippili GC, Giger K, Putt KS, Low PS. DARC, Glycophorin A, Band 3, and GLUT1 Diffusion in Erythrocytes: Insights into Membrane Complexes. Biophysical Journal. PMID 33069269 DOI: 10.1016/j.bpj.2020.09.012  0.784
2020 Nielsen JJ, Low SA, Ramseier NT, Hadap RV, Young NA, Wang M, Low PS. Analysis of the bone fracture targeting properties of osteotropic ligands. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33031877 DOI: 10.1016/j.jconrel.2020.09.047  0.76
2020 Patil RA, Srinivasarao M, Amiji MM, Low PS, Niedre M. Fluorescence Labeling of Circulating Tumor Cells with a Folate Receptor-Targeted Molecular Probe for Diffuse In Vivo Flow Cytometry. Molecular Imaging and Biology. PMID 32519245 DOI: 10.1007/S11307-020-01505-9  0.335
2020 Roy J, Hettiarachchi SU, Kaake M, Mukkamala R, Low PS. Design and validation of fibroblast activation protein alpha targeted imaging and therapeutic agents. Theranostics. 10: 5778-5789. PMID 32483418 DOI: 10.7150/Thno.41409  0.394
2020 Noomuna P, Risinger M, Zhou S, Seu K, Man Y, An R, Sheik DA, Wan J, Little JA, Gurkan UA, Turrini FM, Kalfa T, Low PS. Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease. British Journal of Haematology. PMID 32346864 DOI: 10.1111/Bjh.16671  0.344
2020 Low PS, Luo Q, Napoleon JV, Zhang B. Abstract 3236: Rejuvenation of exhausted CAR-T cells with a targeted TLR7 agonist Immunology. 80: 3236-3236. DOI: 10.1158/1538-7445.Am2020-3236  0.345
2019 Elo P, Li XG, Liljenbäck H, Helin S, Teuho J, Koskensalo K, Saunavaara V, Marjamäki P, Oikonen V, Virta J, Chen Q, Low PS, Knuuti J, Jalkanen S, Airas L, et al. Folate receptor-targeted positron emission tomography of experimental autoimmune encephalomyelitis in rats. Journal of Neuroinflammation. 16: 252. PMID 31796042 DOI: 10.1186/S12974-019-1612-3  0.319
2019 Lu DC, Hannemann A, Wadud R, Rees DC, Brewin JN, Low PS, Gibson JS. The role of WNK in modulation of KCl cotransport activity in red cells from normal individuals and patients with sickle cell anaemia. Pflugers Archiv : European Journal of Physiology. PMID 31729557 DOI: 10.1007/S00424-019-02327-7  0.311
2019 Wagner DR, Karnik S, Gunderson ZJ, Nielsen JJ, Fennimore A, Promer HJ, Lowery JW, Loghmani MT, Low PS, McKinley TO, Kacena MA, Clauss M, Li J. Dysfunctional stem and progenitor cells impair fracture healing with age. World Journal of Stem Cells. 11: 281-296. PMID 31293713 DOI: 10.4252/Wjsc.V11.I6.281  0.77
2019 Kanduluru AK, Srinivasarao M, Wayua C, Low PS. Evaluation of a Neurokinin-1 Receptor-Targeted Technetium-99m Conjugate for Neuroendocrine Cancer Imaging. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 31292915 DOI: 10.1007/S11307-019-01391-W  0.328
2019 Lee YG, Chu H, Lu Y, Leamon CP, Srinivasarao M, Putt KS, Low PS. Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters. Nature Communications. 10: 2681. PMID 31213606 DOI: 10.1038/S41467-019-10565-7  0.627
2019 Kodippili GC, Putt KS, Low PS. Evidence for three populations of the glucose transporter in the human erythrocyte membrane. Blood Cells, Molecules & Diseases. 77: 61-66. PMID 30974390 DOI: 10.1016/J.Bcmd.2019.03.005  0.785
2019 Lu YJ, Chu H, Wheeler LW, Nelson M, Westrick E, Matthaei JF, Cardle II, Johnson A, Gustafson J, Parker N, Vetzel M, Xu LC, Wang EZ, Jensen MC, Klein PJ, ... Low PS, et al. Preclinical Evaluation of Bispecific Adaptor Molecule Controlled Folate Receptor CAR-T Cell Therapy With Special Focus on Pediatric Malignancies. Frontiers in Oncology. 9: 151. PMID 30941303 DOI: 10.3389/Fonc.2019.00151  0.653
2019 Frigerio B, Bizzoni C, Jansen G, Leamon CP, Peters GJ, Low PS, Matherly LH, Figini M. Folate receptors and transporters: biological role and diagnostic/therapeutic targets in cancer and other diseases. Journal of Experimental & Clinical Cancer Research : Cr. 38: 125. PMID 30867007 DOI: 10.1186/S13046-019-1123-1  0.343
2019 Roy J, Kaake M, Low PS. Small molecule targeted NIR dye conjugate for imaging LHRH receptor positive cancers. Oncotarget. 10: 152-160. PMID 30719210 DOI: 10.18632/Oncotarget.26520  0.367
2019 Hoogstins CES, Boogerd LSF, Gaarenstroom KN, Kroon CDd, Beltman JJ, Trimbos JBMZ, Bosse T, Vuyk J, Low PS, Burggraaf J, Vahrmeijer AL. Feasibility of folate receptor-targeted intraoperative fluorescence imaging during staging procedures for early ovarian cancer European Journal of Gynaecological Oncology. 40: 203-208. DOI: 10.12892/Ejgo4412.2019  0.308
2019 Simmons WR, Li Q, Hausman JA, Zheng S, Eaton W, Low PS, Bodine DM. Hemoglobin S Polymerization Can be Inhibited By Alterations in Erythrocyte Glycolysis Blood. 134: 977-977. DOI: 10.1182/Blood-2019-121709  0.336
2018 Szigetvari NM, Dhawan D, Ramos-Vara JA, Leamon CP, Klein PJ, Ruple AA, Heng HG, Pugh MR, Rao S, Vlahov IR, Deshuillers PL, Low PS, Fourez LM, Cournoyer AM, Knapp DW. Phase I/II clinical trial of the targeted chemotherapeutic drug, folate-tubulysin, in dogs with naturally-occurring invasive urothelial carcinoma. Oncotarget. 9: 37042-37053. PMID 30651934 DOI: 10.18632/Oncotarget.26455  0.307
2018 Cho SS, Jeon J, Buch L, Nag S, Nasrallah M, Low PS, Grady MS, Singhal S, Lee JYK. Intraoperative near-infrared imaging with receptor-specific versus passive delivery of fluorescent agents in pituitary adenomas. Journal of Neurosurgery. 1-11. PMID 30554181 DOI: 10.3171/2018.7.Jns181642  0.34
2018 Lee YG, Marks I, Srinivasarao M, Kanduluru AK, Mahalingam SM, Liu X, Chu H, Low PS. Use of a single CAR T cell and several bispecific adapters facilitates eradication of multiple antigenically different solid tumors. Cancer Research. PMID 30482775 DOI: 10.1158/0008-5472.Can-18-1834  0.525
2018 Elsayed MSA, Nielsen JJ, Park S, Park J, Liu Q, Kim CH, Pommier Y, Agama K, Low PS, Cushman M. Application of Sequential Palladium Catalysis for the Discovery of Janus Kinase Inhibitors in the Benzo[ c]pyrrolo[2,3- h][1,6]naphthyridin-5-one (BPN) Series. Journal of Medicinal Chemistry. PMID 30460842 DOI: 10.1021/Acs.Jmedchem.8B00510  0.769
2018 Wang M, Park S, Nam Y, Nielsen J, Low SA, Srinivasarao M, Low PS. Bone fracture-targeted dasatinib-oligoaspartic acid conjugate potently accelerates fracture repair. Bioconjugate Chemistry. PMID 30380292 DOI: 10.1021/Acs.Bioconjchem.8B00660  0.763
2018 Mahalingam SM, Kularatne SA, Myers CH, Gagare P, Norshi M, Liu X, Singhal S, Low PS. Evaluation of Novel Tumor-Targeted Near-Infrared Probe for Fluorescence-Guided Surgery of Cancer. Journal of Medicinal Chemistry. PMID 30296376 DOI: 10.1021/Acs.Jmedchem.8B01115  0.804
2018 Mahalingam S, Chu H, Liu X, Leamon CP, Low PS. Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence Imaging of Hypoxic Tumors. Bioconjugate Chemistry. PMID 30185025 DOI: 10.1021/Acs.Bioconjchem.8B00509  0.549
2018 Newton AD, Predina JD, Nie S, Low PS, Singhal S. Intraoperative fluorescence imaging in thoracic surgery. Journal of Surgical Oncology. PMID 30098293 DOI: 10.1002/Jso.25149  0.317
2018 Roy J, Kaake M, Srinivasarao M, Low PS. A targeted tubulysin B hydrazide conjugate for the treatment of LHRH receptor-positive cancers. Bioconjugate Chemistry. PMID 29851465 DOI: 10.1021/Acs.Bioconjchem.8B00164  0.368
2018 Marks IS, Gardeen SS, Kurdziel SJ, Nicolaou ST, Woods JE, Kularatne SA, Low PS. Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers. Molecular Pharmaceutics. PMID 29715036 DOI: 10.1021/Acs.Molpharmaceut.8B00139  0.804
2018 Zhou Y, Unno K, Hyjek E, Liu H, Zimmerman T, Karmakar S, Putt KS, Shen J, Low PS, Wickrema A. Expression of functional folate receptors in multiple myeloma. Leukemia & Lymphoma. 1-8. PMID 29616859 DOI: 10.1080/10428194.2018.1453066  0.353
2018 Low PS, Singhal S, Srinivasarao M. Fluorescence-guided surgery of cancer: applications, tools and perspectives. Current Opinion in Chemical Biology. 45: 64-72. PMID 29579618 DOI: 10.1016/J.Cbpa.2018.03.002  0.331
2018 Predina JD, Newton AD, Xia L, Corbett C, Connolly C, Shin M, Sulyok LF, Litzky L, Deshpande C, Nie S, Kularatne SA, Low PS, Singhal S. An open label trial of folate receptor-targeted intraoperative molecular imaging to localize pulmonary squamous cell carcinomas. Oncotarget. 9: 13517-13529. PMID 29568374 DOI: 10.18632/Oncotarget.24399  0.785
2018 Zhang H, Kanduluru AK, Desai P, Ahad A, Carlin SD, Tandon N, Weber W, Low PS. Synthesis and evaluation of a novelCu/Ga-labeled neurokinin 1 receptor antagonist for in vivo targeting of NK1R-positive tumor xenografts. Bioconjugate Chemistry. PMID 29466853 DOI: 10.1021/Acs.Bioconjchem.8B00063  0.37
2018 Rangasamy L, Chelvam V, Kanduluru AK, Srinivasarao M, Bandara AN, You F, Orellana E, Kasinski AL, Low PS. New mechanism for release of endosomal contents: osmotic lysis via nigericin-mediated K/Hexchange. Bioconjugate Chemistry. PMID 29446616 DOI: 10.1021/Acs.Bioconjchem.7B00714  0.345
2018 Shen J, Hu Y, Putt KS, Singhal S, Han H, Visscher DW, Murphy LM, Low PS. Assessment of folate receptor alpha and beta expression in selection of lung and pancreatic cancer patients for receptor targeted therapies. Oncotarget. 9: 4485-4495. PMID 29435118 DOI: 10.18632/Oncotarget.23321  0.321
2018 Boogerd LSF, Hoogstins CES, Gaarenstroom KN, de Kroon CD, Beltman JJ, Bosse T, Stelloo E, Vuyk J, Low PS, Burggraaf J, Vahrmeijer AL. Folate receptor-α targeted near-infrared fluorescence imaging in high-risk endometrial cancer patients: a tissue microarray and clinical feasibility study. Oncotarget. 9: 791-801. PMID 29416655 DOI: 10.18632/Oncotarget.23155  0.324
2018 Poh S, Chelvam V, Ayala-López W, Putt KS, Low PS. Selective liposome targeting of folate receptor positive immune cells in inflammatory diseases. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 29410110 DOI: 10.1016/J.Nano.2018.01.009  0.616
2018 Lu YJ, Chu H, Wheeler LW, Nelson M, Westrick EM, Vetzel MR, Klein PJ, Johnson AJ, Yokoyama JK, Gustafson JA, Jensen MC, Lee Y, Low PS, Leamon CP. Abstract LB-109: Adaptor controlled CAR-T cell immunotherapy for treatment of folate receptor-alpha/beta positive solid and liquid tumors Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-109  0.555
2018 Lee YG, Marks I, Srinivasarao M, Kanduluru AK, Mahalingam SM, Chu H, Low PS. Abstract 3571: Use of a universal CAR T cell plus bispecific adapters to eradicate antigenically heterogeneous tumors Cancer Research. 78: 3571-3571. DOI: 10.1158/1538-7445.Am2018-3571  0.551
2018 Chu H, Lu Y, Lee YG, Wheeler L, Nelson M, Westrick E, Vetzel M, Klein PJ, Low PS, Leamon CP. Abstract 2546: Regulation of CAR-T cell therapy in real time using bispecific small molecule adaptors and monospecific competitors Cancer Research. 78: 2546-2546. DOI: 10.1158/1538-7445.Am2018-2546  0.639
2018 Newton AD, Predina JD, Corbett CJ, Shin MH, Sulyok LGF, Baldassari M, Low PS, Singhal S. 854 - Intraoperative Molecular Imaging with a Tumor Hypoxia Targeted Near Infrared Contrast Agent Identifies Subcentimeter Tumor Deposits in a Murine Colorectal Carcinomatosis Model Gastroenterology. 154: S-1287-S-1288. DOI: 10.1016/S0016-5085(18)34225-2  0.316
2017 Predina JD, Newton AD, Connolly C, Dunbar A, Baldassari M, Deshpande C, Cantu E, Stadanlick J, Kularatne SA, Low PS, Singhal S. Identification of a Folate Receptor-Targeted Near-Infrared Molecular Contrast Agent to Localize Pulmonary Adenocarcinomas. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 29241970 DOI: 10.1016/J.Ymthe.2017.10.016  0.788
2017 Chen Q, Meng X, McQuade P, Rubins D, Lin SA, Zeng Z, Haley H, Miller P, Gonzalez Trotter D, Low PS. Folate-PEG-NOTA-Al18F, A New Folate Based Radiotracer for PET imaging of Folate Receptor-Positive Tumors. Molecular Pharmaceutics. PMID 29028357 DOI: 10.1021/Acs.Molpharmaceut.7B00415  0.314
2017 Poh S, Chelvam V, Kelderhouse LE, Ayala-López W, Vaitilingam B, Putt KS, Low PS. Folate-conjugated liposomes target and deliver therapeutics to immune cells in a rat model of rheumatoid arthritis. Nanomedicine (London, England). 12: 2441-2451. PMID 28972462 DOI: 10.2217/Nnm-2017-0166  0.591
2017 Kanduluru AK, Low PS. Development of a Ligand-Targeted Therapeutic Agent for Neurokinin-1 Receptor Expressing Cancers. Molecular Pharmaceutics. PMID 28969417 DOI: 10.1021/Acs.Molpharmaceut.7B00583  0.39
2017 Mahalingam SM, Dudkin VY, Goldberg S, Klein D, Yi F, Singhal S, ONeil KT, Low PS. Evaluation of a Centyrin-based near-infrared probe for fluorescence-guided surgery of epidermal growth factor receptor positive tumors. Bioconjugate Chemistry. PMID 28945346 DOI: 10.1021/Acs.Bioconjchem.7B00566  0.353
2017 Srinivasarao M, Low PS. Ligand-Targeted Drug Delivery. Chemical Reviews. PMID 28898067 DOI: 10.1021/Acs.Chemrev.7B00013  0.35
2017 Poh S, Putt KS, Low PS. Folate-targeted dendrimers selectively accumulate at sites of inflammation in mouse models of ulcerative colitis and atherosclerosis. Biomacromolecules. PMID 28863264 DOI: 10.1021/Acs.Biomac.7B00728  0.617
2017 Lee JYK, Cho SS, Zeh R, Pierce JT, Martinez-Lage M, Adappa ND, Palmer JN, Newman JG, Learned KO, White C, Kharlip J, Snyder P, Low PS, Singhal S, Grady MS. Folate receptor overexpression can be visualized in real time during pituitary adenoma endoscopic transsphenoidal surgery with near-infrared imaging. Journal of Neurosurgery. 1-14. PMID 28841122 DOI: 10.3171/2017.2.Jns163191  0.309
2017 Orellana EA, Tenneti S, Rangasamy L, Lyle LT, Low PS, Kasinski AL. FolamiRs: Ligand-targeted, vehicle-free delivery of microRNAs for the treatment of cancer. Science Translational Medicine. 9. PMID 28768807 DOI: 10.1126/Scitranslmed.Aam9327  0.354
2017 Merzel RL, Frey C, Chen J, Garn R, van Dongen MA, Dougherty CA, Kandaluru A, Low PS, Marsh ENG, Banaszak Holl MM. Conjugation dependent interaction of folic acid with folate binding protein. Bioconjugate Chemistry. PMID 28731321 DOI: 10.1021/Acs.Bioconjchem.7B00373  0.326
2017 Pantaleo A, Kesely KR, Pau MC, Tsamesidis I, Schwarzer E, Skorokhod OA, Chien HD, Ponzi M, Bertuccini L, Low PS, Turrini FM. Syk Inhibitors interfere with erythrocyte membrane modification during P. falciparum growth and suppress parasite egress. Blood. PMID 28634183 DOI: 10.1182/Blood-2016-11-748053  0.312
2017 Keating JJ, Runge JJ, Singhal S, Nims S, Venegas O, Durham AC, Swain G, Nie S, Low PS, Holt DE. Intraoperative near-infrared fluorescence imaging targeting folate receptors identifies lung cancer in a large-animal model. Cancer. 123: 1051-1060. PMID 28263385 DOI: 10.1002/Cncr.30419  0.311
2017 Huang W, Chang CL, Brault ND, Gur O, Wang Z, Jalal SI, Low PS, Ratliff TL, Pili R, Savran CA. Separation and dual detection of prostate cancer cells and protein biomarkers using a microchip device. Lab On a Chip. PMID 28054089 DOI: 10.1039/C6Lc01279E  0.325
2017 Lee YG, Chu H, Low PS. Abstract LB-187: New methods for controlling CAR T cell-mediated cytokine storms Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-187  0.534
2016 Li G, Low PS. Synthesis and evaluation of a ligand targeting the μ and δ opioid receptors for drug delivery to lung cancer. Bioorganic & Medicinal Chemistry Letters. PMID 28291693 DOI: 10.1016/J.Bmcl.2016.06.067  0.346
2016 Newton AD, Kennedy GT, Predina JD, Low PS, Singhal S. Intraoperative molecular imaging to identify lung adenocarcinomas. Journal of Thoracic Disease. 8: S697-S704. PMID 28066672 DOI: 10.21037/Jtd.2016.09.50  0.319
2016 Bandara NA, Bates CD, Lu Y, Hoylman EK, Low PS. Folate-Hapten Mediated Immunotherapy Synergizes with Vascular Endothelial Growth Factor Receptor Inhibitors in Treating Murine Models of Cancer. Molecular Cancer Therapeutics. PMID 27980109 DOI: 10.1158/1535-7163.Mct-16-0569  0.567
2016 Lv PC, Roy J, Putt KS, Low PS. Evaluation of Nonpeptidic Ligand Conjugates for Treatment of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers. Molecular Cancer Therapeutics. PMID 27980101 DOI: 10.1158/1535-7163.Mct-16-0537  0.387
2016 Shum CF, Bahler CD, Low PS, Ratliff TL, Kheyfets SV, Natarajan JP, Sandusky GE, Sundaram CP. Novel Use of Folate-Targeted Intraoperative Fluorescence, OTL38, in Robot-Assisted Laparoscopic Partial Nephrectomy: Report of the First Three Cases. Journal of Endourology Case Reports. 2: 189-197. PMID 27868096 DOI: 10.1089/Cren.2016.0104  0.316
2016 Puchulu-Campanella E, Turrini FM, Li YH, Low PS. Global transformation of erythrocyte properties via engagement of an SH2-like sequence in band 3. Proceedings of the National Academy of Sciences of the United States of America. PMID 27856737 DOI: 10.1073/Pnas.1611904113  0.342
2016 Chu H, McKenna MM, Krump NA, Zheng S, Mendelsohn L, Thein SL, Garrett LJ, Bodine DM, Low PS. Reversible binding of hemoglobin to band 3 constitutes the molecular switch that mediates O2 regulation of erythrocyte properties. Blood. PMID 27688804 DOI: 10.1182/Blood-2016-01-692079  0.534
2016 Spector J, Kodippili GC, Ritchie K, Low PS. Single Molecule Studies of the Diffusion of Band 3 in Sickle Cell Erythrocytes. Plos One. 11: e0162514. PMID 27598991 DOI: 10.1371/Journal.Pone.0162514  0.796
2016 Giger K, Habib I, Ritchie K, Low PS. Diffusion of glycophorin A in human erythrocytes. Biochimica Et Biophysica Acta. 1858: 2839-2845. PMID 27580023 DOI: 10.1016/J.Bbamem.2016.08.012  0.776
2016 Kanduluru AK, Srinivasarao M, Low PS. Design, Synthesis and Evaluation of a Neurokinin 1 Receptor-Targeted Near IR Dye for Fluorescence Guided Surgery of Neuroendocrine Cancers. Bioconjugate Chemistry. PMID 27529726 DOI: 10.1021/Acs.Bioconjchem.6B00374  0.372
2016 Franco T, Chu H, Low PS. Identification of Adducin-Binding Residues on the Cytoplasmic Domain of Erythrocyte Membrane Protein, Band 3. The Biochemical Journal. PMID 27435097 DOI: 10.1042/Bcj20160328  0.675
2016 Lv PC, Putt KS, Low PS. Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers. Bioconjugate Chemistry. PMID 27362480 DOI: 10.1021/Acs.Bioconjchem.6B00271  0.38
2016 Hoogstins CE, Tummers QR, Gaarenstroom KN, de Kroon CD, Trimbos JB, Bosse T, Smit VT, Vuyk J, van de Velde CJ, Cohen AF, Low PS, Burggraaf J, Vahrmeijer AL. A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 22: 2929-38. PMID 27306792 DOI: 10.1158/1078-0432.Ccr-15-2640  0.338
2016 Varghese B, Paulos C, Low PS. Optimization of Folate-Targeted Immunotherapy for the Treatment of Experimental Arthritis. Inflammation. PMID 27206918 DOI: 10.1007/S10753-016-0366-7  0.609
2016 Chen Q, Meng X, McQuade P, Rubins D, Lin SA, Zeng Z, Haley H, Miller P, Gonzalez Trotter D, Low PS. Synthesis and Preclinical Evaluation of Folate-NOTA-Al18F for PET Imaging of Folate Receptor-Positive Tumors. Molecular Pharmaceutics. PMID 27054811 DOI: 10.1021/Acs.Molpharmaceut.5B00989  0.336
2016 Lv PC, Roy J, Putt KS, Low PS. Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic Tumors. Molecular Pharmaceutics. PMID 27043317 DOI: 10.1021/Acs.Molpharmaceut.6B00065  0.354
2016 Tummers QR, Hoogstins CE, Gaarenstroom KN, de Kroon CD, van Poelgeest MI, Vuyk J, Bosse T, Smit VT, van de Velde CJ, Cohen AF, Low PS, Burggraaf J, Vahrmeijer AL. Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17. Oncotarget. PMID 27014973 DOI: 10.18632/Oncotarget.8282  0.312
2016 Boogerd LS, Boonstra MC, Beck AJ, Charehbili A, Hoogstins CE, Prevoo HA, Singhal S, Low PS, van de Velde CJ, Vahrmeijer AL. Concordance of folate receptor-α expression between biopsy, primary tumor and metastasis in breast cancer and lung cancer patients. Oncotarget. PMID 26943581 DOI: 10.18632/Oncotarget.7856  0.301
2016 Roy J, Putt KS, Coppola D, Leon ME, Khalil FK, Centeno BA, Clark N, Stark VE, Morse DL, Low PS. Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue. Oncotarget. PMID 26910279 DOI: 10.18632/Oncotarget.7522  0.302
2016 Chen J, van Dongen MA, Merzel RL, Dougherty CA, Orr BG, Kanduluru AK, Low PS, Marsh EN, Banaszak Holl MM. Substrate-Triggered Exosite Binding: Synergistic Dendrimer/Folic Acid Action for Achieving Specific, Tight-Binding to Folate Binding Protein. Biomacromolecules. PMID 26815158 DOI: 10.1021/Acs.Biomac.5B01586  0.31
2016 Lee YG, Chu H, Tenneti S, Kanduluru AK, Low PS. Abstract LB-254: A universal remedy for CAR T cell limitations Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-254  0.552
2016 Roy J, Wayua C, Low PS. Abstract 2195: Small molecule drug conjugates targeted to cholecystokinin 2 receptors Cancer Research. 76: 2195-2195. DOI: 10.1158/1538-7445.Am2016-2195  0.406
2015 De Jesus E, Keating JJ, Kularatne SA, Jiang J, Judy R, Predina J, Nie S, Low P, Singhal S. Comparison of Folate Receptor Targeted Optical Contrast Agents for Intraoperative Molecular Imaging. International Journal of Molecular Imaging. 2015: 469047. PMID 26491562 DOI: 10.1155/2015/469047  0.798
2015 de Boer E, Crane LM, van Oosten M, van der Vegt B, van der Sluis T, Kooijman P, Low PS, van der Zee AG, Arts HJ, van Dam GM, Bart J. Folate Receptor-Beta Has Limited Value for Fluorescent Imaging in Ovarian, Breast and Colorectal Cancer. Plos One. 10: e0135012. PMID 26248049 DOI: 10.1371/Journal.Pone.0135012  0.302
2015 Sega MF, Chu H, Christian JA, Low PS. Fluorescence assay of the interaction between hemoglobin and the cytoplasmic domain of erythrocyte membrane band 3. Blood Cells, Molecules & Diseases. 55: 266-71. PMID 26227857 DOI: 10.1016/J.Bcmd.2015.07.004  0.52
2015 Lu Y, Parker N, Kleindl PJ, Cross VA, Wollak K, Westrick E, Stinnette TW, Gehrke MA, Wang K, Santhapuram HK, You F, Hahn SJ, Vaughn JF, Klein PJ, Vlahov IR, ... Low PS, et al. Anti-Inflammatory Activity of a Novel Folic Acid Targeted Conjugate of the mTOR Inhibitor Everolimus. Molecular Medicine (Cambridge, Mass.). PMID 26181632 DOI: 10.2119/Molmed.2015.00040  0.554
2015 Huang W, Chang CL, Chan BD, Jalal SI, Matei DE, Low PS, Savran CA. Concurrent Detection of Cellular and Molecular Cancer Markers Using an Immunomagnetic Flow System. Analytical Chemistry. PMID 26165381 DOI: 10.1021/Acs.Analchem.5B02215  0.342
2015 Wayua C, Roy J, Putt KS, Low PS. Selective Tumor Targeting of Desacetyl Vinblastine Hydrazide and Tubulysin B via Conjugation to a Cholecystokinin 2 Receptor (CCK2R) Ligand. Molecular Pharmaceutics. PMID 26043355 DOI: 10.1021/Acs.Molpharmaceut.5B00218  0.379
2015 Poh S, Chelvam V, Low PS. Comparison of nanoparticle penetration into solid tumors and sites of inflammation: studies using targeted and nontargeted liposomes. Nanomedicine (London, England). 10: 1439-49. PMID 25996118 DOI: 10.2217/Nnm.14.237  0.558
2015 Shen J, Putt KS, Visscher DW, Murphy L, Cohen C, Singhal S, Sandusky G, Feng Y, Dimitrov DS, Low PS. Assessment of folate receptor-β expression in human neoplastic tissues. Oncotarget. 6: 14700-9. PMID 25909292 DOI: 10.18632/Oncotarget.3739  0.367
2015 Lynn RC, Poussin M, Kalota A, Feng Y, Low PS, Dimitrov DS, Powell DJ. Targeting of folate receptor β on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells. Blood. 125: 3466-76. PMID 25887778 DOI: 10.1182/Blood-2014-11-612721  0.319
2015 Roy J, Nguyen TX, Kanduluru AK, Venkatesh C, Lv W, Reddy PV, Low PS, Cushman M. DUPA conjugation of a cytotoxic indenoisoquinoline topoisomerase I inhibitor for selective prostate cancer cell targeting. Journal of Medicinal Chemistry. 58: 3094-103. PMID 25822623 DOI: 10.1021/Jm5018384  0.665
2015 Li G, Low PS. Synthesis and evaluation of a ligand targeting the somatostatin-2 receptor for drug delivery to neuroendocrine cancers. Bioorganic & Medicinal Chemistry Letters. 25: 1792-8. PMID 25791453 DOI: 10.1016/J.Bmcl.2015.02.033  0.389
2015 Srinivasarao M, Galliford CV, Low PS. Principles in the design of ligand-targeted cancer therapeutics and imaging agents. Nature Reviews. Drug Discovery. 14: 203-19. PMID 25698644 DOI: 10.1038/Nrd4519  0.355
2015 Wayua C, Low PS. Evaluation of a nonpeptidic ligand for imaging of cholecystokinin 2 receptor-expressing cancers. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 113-9. PMID 25500824 DOI: 10.2967/Jnumed.114.144998  0.368
2015 Wandersee NJ, Maciaszek JL, Giger KM, Hanson MS, Zheng S, Guo Y, Mickelson B, Hillery CA, Lykotrafitis G, Low PS, Hogg N. Dietary supplementation with docosahexanoic acid (DHA) increases red blood cell membrane flexibility in mice with sickle cell disease. Blood Cells, Molecules & Diseases. 54: 183-8. PMID 25488613 DOI: 10.1016/J.Bcmd.2014.11.004  0.761
2015 Wheeler LW, Lu Y, Cross V, Lloyd A, Parker N, Qi L, Wang K, Wang I, Hahn S, Vaughn J, Vlahov IP, Low PS, Leamon CP. Abstract 4495: Small molecule approach for targeting tumor-associated macrophages via a functional FRβ Cancer Research. 75: 4495-4495. DOI: 10.1158/1538-7445.Am2015-4495  0.563
2015 Lynn RC, Poussin M, Feng Y, Schutsky K, Kalota A, Low PS, Dimitrov DS, Powell DJ. 285. Exploring On-Target Hematopoietic Toxicity With Highly Potent, High Affinity FRβ-Specific CAR T Cells for AML Molecular Therapy. 23: S114. DOI: 10.1016/S1525-0016(16)33894-1  0.341
2015 Sega MF, Chu H, Christian JA, Low PS. Fluorescence assay of the interaction between hemoglobin and the cytoplasmic domain of erythrocyte membrane band 3 Blood Cells, Molecules, and Diseases. 55: 266-271. DOI: 10.1016/j.bcmd.2015.07.004  0.447
2014 Tsai EH, Bentz BZ, Chelvam V, Gaind V, Webb KJ, Low PS. In vivo mouse fluorescence imaging for folate-targeted delivery and release kinetics. Biomedical Optics Express. 5: 2662-78. PMID 26236559 DOI: 10.1364/Boe.5.002662  0.385
2014 Okusanya OT, Deshpande C, Barbosa EM, Aggarwal C, Simone CB, Jiang J, Judy R, DeJesus E, Albelda S, Nie S, Low PS, Singhal S. Molecular imaging to identify tumor recurrence following chemoradiation in a hostile surgical environment. Molecular Imaging. 13. PMID 25442640 DOI: 10.2310/7290.2014.00051  0.309
2014 Varghese B, Vlashi E, Xia W, Ayala Lopez W, Paulos CM, Reddy J, Xu LC, Low PS. Folate receptor-β in activated macrophages: ligand binding and receptor recycling kinetics. Molecular Pharmaceutics. 11: 3609-16. PMID 25166491 DOI: 10.1021/Mp500348E  0.776
2014 Amato RJ, Shetty A, Lu Y, Ellis PR, Mohlere V, Carnahan N, Low PS. A Phase I/Ib study of folate immune (EC90 vaccine administered with GPI-0100 adjuvant followed by EC17) with interferon-α and interleukin-2 in patients with renal cell carcinoma. Journal of Immunotherapy (Hagerstown, Md. : 1997). 37: 237-44. PMID 24714357 DOI: 10.1097/Cji.0000000000000029  0.472
2014 Wang B, Galliford CV, Low PS. Guiding principles in the design of ligand-targeted nanomedicines. Nanomedicine (London, England). 9: 313-30. PMID 24552563 DOI: 10.2217/Nnm.13.175  0.342
2014 Sun JY, Shen J, Thibodeaux J, Huang G, Wang Y, Gao J, Low PS, Dimitrov DS, Sumer BD. In vivo optical imaging of folate receptor-β in head and neck squamous cell carcinoma. The Laryngoscope. 124: E312-9. PMID 24448885 DOI: 10.1002/Lary.24606  0.363
2014 Bandara NA, Hansen MJ, Low PS. Effect of receptor occupancy on folate receptor internalization. Molecular Pharmaceutics. 11: 1007-13. PMID 24446917 DOI: 10.1021/Mp400659T  0.351
2014 Wayua C, Low PS. Evaluation of a cholecystokinin 2 receptor-targeted near-infrared dye for fluorescence-guided surgery of cancer. Molecular Pharmaceutics. 11: 468-76. PMID 24325469 DOI: 10.1021/Mp400429H  0.387
2014 Tsai EHR, Bentz BZ, Chelvam V, Gaind V, Webb KJ, Low PS. In vivo fluorescence imaging for folate-targeted kinetics Frontiers in Optics, Fio 2014. DOI: 10.1364/Fio.2014.Fm4F.1  0.343
2014 Bandara NA, Low PS. Abstract 2593: Multitargeted receptor tyrosine kinase inhibitors synergize with folate-hapten mediated immunotherapy in folate receptor positive cancers Cancer Research. 74: 2593-2593. DOI: 10.1158/1538-7445.Am2014-2593  0.377
2013 Weber CJ, Müller S, Safley SA, Gordon KB, Amancha P, Villinger F, Camp VM, Lipowska M, Sharma J, Müller C, Schibli R, Low PS, Leamon CP, Halkar RK. Expression of functional folate receptors by human parathyroid cells. Surgery. 154: 1385-93; discussion . PMID 24206618 DOI: 10.1016/J.Surg.2013.06.045  0.312
2013 Vlashi E, Kelderhouse LE, Sturgis JE, Low PS. Effect of folate-targeted nanoparticle size on their rates of penetration into solid tumors. Acs Nano. 7: 8573-82. PMID 24020507 DOI: 10.1021/Nn402644G  0.69
2013 Grapp M, Wrede A, Schweizer M, Hüwel S, Galla HJ, Snaidero N, Simons M, Bückers J, Low PS, Urlaub H, Gärtner J, Steinfeld R. Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma. Nature Communications. 4: 2123. PMID 23828504 DOI: 10.1038/Ncomms3123  0.31
2013 Kularatne SA, Bélanger MJ, Meng X, Connolly BM, Vanko A, Suresch DL, Guenther I, Wang S, Low PS, McQuade P, Trotter DG. Comparative analysis of folate derived PET imaging agents with [(18)F]-2-fluoro-2-deoxy-d-glucose using a rodent inflammatory paw model. Molecular Pharmaceutics. 10: 3103-11. PMID 23819524 DOI: 10.1021/Mp4001684  0.784
2013 Kelderhouse LE, Chelvam V, Wayua C, Mahalingam S, Poh S, Kularatne SA, Low PS. Development of tumor-targeted near infrared probes for fluorescence guided surgery. Bioconjugate Chemistry. 24: 1075-80. PMID 23642154 DOI: 10.1021/Bc400131A  0.811
2013 Shen J, Chelvam V, Cresswell G, Low PS. Use of folate-conjugated imaging agents to target alternatively activated macrophages in a murine model of asthma. Molecular Pharmaceutics. 10: 1918-27. PMID 23641923 DOI: 10.1021/Mp3006962  0.324
2013 Amato RJ, Shetty A, Lu Y, Ellis R, Low PS. A phase I study of folate immune therapy (EC90 vaccine administered with GPI-0100 adjuvant followed by EC17) in patients with renal cell carcinoma. Journal of Immunotherapy (Hagerstown, Md. : 1997). 36: 268-75. PMID 23603861 DOI: 10.1097/Cji.0B013E3182917F59  0.479
2013 Gent YY, Weijers K, Molthoff CF, Windhorst AD, Huisman MC, Smith DE, Kularatne SA, Jansen G, Low PS, Lammertsma AA, van der Laken CJ. Evaluation of the novel folate receptor ligand [18F]fluoro-PEG-folate for macrophage targeting in a rat model of arthritis. Arthritis Research & Therapy. 15: R37. PMID 23452511 DOI: 10.1186/Ar4191  0.783
2013 Dhawan D, Ramos-Vara JA, Naughton JF, Cheng L, Low PS, Rothenbuhler R, Leamon CP, Parker N, Klein PJ, Vlahov IR, Reddy JA, Koch M, Murphy L, Fourez LM, Stewart JC, et al. Targeting folate receptors to treat invasive urinary bladder cancer. Cancer Research. 73: 875-84. PMID 23204225 DOI: 10.1158/0008-5472.Can-12-2101  0.349
2013 Puchulu-Campanella E, Chu H, Anstee DJ, Galan JA, Tao WA, Low PS. Identification of the components of a glycolytic enzyme metabolon on the human red blood cell membrane. The Journal of Biological Chemistry. 288: 848-58. PMID 23150667 DOI: 10.1074/Jbc.M112.428573  0.541
2013 Stefanovic M, Puchulu-Campanella E, Kodippili G, Low PS. Oxygen regulates the band 3-ankyrin bridge in the human erythrocyte membrane. The Biochemical Journal. 449: 143-50. PMID 23013433 DOI: 10.1042/Bj20120869  0.799
2013 Cagle PT, Zhai QJ, Murphy L, Low PS. Folate receptor in adenocarcinoma and squamous cell carcinoma of the lung: potential target for folate-linked therapeutic agents. Archives of Pathology & Laboratory Medicine. 137: 241-4. PMID 22984810 DOI: 10.5858/Arpa.2012-0176-Oa  0.334
2013 Gent YY, Weijers K, Molthoff CF, Windhorst AD, Huisman MC, Smith DE, Kularatne SA, Jansen G, Low PS, Lammertsma AA, van der Laken CJ. AB0761 Synthesis and evaluation of the novel folate receptor ligand [18f]fluoro-peg-folate for macrophage targeting in a rat model of arthritis Annals of the Rheumatic Diseases. 72: A1021.3-A1021. DOI: 10.1136/Annrheumdis-2013-Eular.3083  0.782
2012 Grey JL, Kodippili GC, Simon K, Low PS. Identification of contact sites between ankyrin and band 3 in the human erythrocyte membrane. Biochemistry. 51: 6838-46. PMID 22861190 DOI: 10.1021/Bi300693K  0.783
2012 Chu H, Puchulu-Campanella E, Galan JA, Tao WA, Low PS, Hoffman JF. Identification of cytoskeletal elements enclosing the ATP pools that fuel human red blood cell membrane cation pumps. Proceedings of the National Academy of Sciences of the United States of America. 109: 12794-9. PMID 22745158 DOI: 10.1073/Pnas.1209014109  0.494
2012 Vaitilingam B, Chelvam V, Kularatne SA, Poh S, Ayala-Lopez W, Low PS. A folate receptor-α-specific ligand that targets cancer tissue and not sites of inflammation. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1127-34. PMID 22693311 DOI: 10.2967/Jnumed.111.099390  0.811
2012 Johnson EO, Chang KH, Ghosh S, Venkatesh C, Giger K, Low PS, Shah K. LIMK2 is a crucial regulator and effector of Aurora-A-kinase-mediated malignancy. Journal of Cell Science. 125: 1204-16. PMID 22492986 DOI: 10.1242/Jcs.092304  0.78
2012 Henne WA, Rothenbuhler R, Ayala-Lopez W, Xia W, Varghese B, Low PS. Imaging sites of infection using a 99mTc-labeled folate conjugate targeted to folate receptor positive macrophages. Molecular Pharmaceutics. 9: 1435-40. PMID 22468849 DOI: 10.1021/Mp3000138  0.308
2012 Sega MF, Chu H, Christian J, Low PS. Interaction of deoxyhemoglobin with the cytoplasmic domain of murine erythrocyte band 3. Biochemistry. 51: 3264-72. PMID 22452706 DOI: 10.1021/Bi201623V  0.518
2012 Yang JJ, Kularatne SA, Chen X, Low PS, Wang E. Characterization of in vivo disulfide-reduction mediated drug release in mouse kidneys. Molecular Pharmaceutics. 9: 310-7. PMID 22171616 DOI: 10.1021/Mp200483T  0.788
2012 Kodippili GC, Spector J, Hale J, Giger K, Hughes MR, McNagny KM, Birkenmeier C, Peters L, Ritchie K, Low PS. Analysis of the mobilities of band 3 populations associated with ankyrin protein and junctional complexes in intact murine erythrocytes. The Journal of Biological Chemistry. 287: 4129-38. PMID 22147703 DOI: 10.1074/Jbc.M111.294439  0.777
2012 Pantaleo A, Ferru E, Vono R, Giribaldi G, Lobina O, Nepveu F, Ibrahim H, Nallet JP, Carta F, Mannu F, Pippia P, Campanella E, Low PS, Turrini F. New antimalarial indolone-N-oxides, generating radical species, destabilize the host cell membrane at early stages of Plasmodium falciparum growth: role of band 3 tyrosine phosphorylation. Free Radical Biology & Medicine. 52: 527-36. PMID 22142474 DOI: 10.1016/J.Freeradbiomed.2011.11.008  0.318
2012 Yang J, Vlashi E, Low P. Folate-linked drugs for the treatment of cancer and inflammatory diseases. Sub-Cellular Biochemistry. 56: 163-79. PMID 22116699 DOI: 10.1007/978-94-007-2199-9_9  0.701
2012 Henne WA, Kularatne SA, Ayala-López W, Doorneweerd DD, Stinnette TW, Lu Y, Low PS. Synthesis and activity of folate conjugated didemnin B for potential treatment of inflammatory diseases. Bioorganic & Medicinal Chemistry Letters. 22: 709-12. PMID 22100311 DOI: 10.1016/J.Bmcl.2011.10.042  0.788
2012 Wandersee NJ, Hanson MS, Maciaszek JL, Larson MC, Giger KM, Zheng S, Retherford DM, Mickelson B, Stucky CL, Low PS, Lykotrafitis G, Hogg N, Hillery CA. Dietary Supplementation with Docosahexanoic Acid (DHA) Improves RBC Flexibility and Reduces Cold Hypersensitivity in Mice with Sickle Cell Disease. Blood. 120: 2116-2116. DOI: 10.1182/Blood.V120.21.2116.2116  0.755
2012 Vaitilingam B, Chelvam V, Kularatne SA, Poh S, Ayala-Lopez W, Low PS. Abstract 5745: Synthesis and characterization of a folate receptor alpha-specific ligand for distinguishing cancer tissue from sites of inflammation Cancer Research. 72: 5745-5745. DOI: 10.1158/1538-7445.Am2012-5745  0.8
2012 Wayua C, Low PS. Abstract 5737: Development of targeted imaging agents for Cholecystokinin 2 receptor expressing cancers Cancer Research. 72: 5737-5737. DOI: 10.1158/1538-7445.Am2012-5737  0.425
2012 Kelderhouse LE, Chelvam V, Wayua C, Sakkarapalayam MM, Poh S, Kularatne SA, Low PS. Abstract 374: Development of tumor-targeted near infrared dyes for fluorescence guided surgery Cancer Research. 72: 374-374. DOI: 10.1158/1538-7445.Am2012-374  0.799
2012 Hanson M, Maciaszek JL, Larson MC, Giger KM, Zheng S, Retherford DM, Mickelson B, Stucky C, Low PS, Lykotrafitis G, Hogg N, Hillery CA, Wandersee NJ. Dietary Supplementation with Docosahexanoic Acid (DHA) Improves RBC Membrane Flexibility and Reduces Cold Hypersensitivity in Mice with Sickle Cell Disease Free Radical Biology and Medicine. 53: S162. DOI: 10.1016/J.Freeradbiomed.2012.10.442  0.773
2012 Lu Y, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents Advanced Drug Delivery Reviews. 64: 342-352. DOI: 10.1016/j.addr.2012.09.020  0.434
2011 van Dam GM, Themelis G, Crane LM, Harlaar NJ, Pleijhuis RG, Kelder W, Sarantopoulos A, de Jong JS, Arts HJ, van der Zee AG, Bart J, Low PS, Ntziachristos V. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. Nature Medicine. 17: 1315-9. PMID 21926976 DOI: 10.1038/Nm.2472  0.339
2011 Bao N, Kodippili GC, Giger KM, Fowler VM, Low PS, Lu C. Single-cell electrical lysis of erythrocytes detects deficiencies in the cytoskeletal protein network. Lab On a Chip. 11: 3053-6. PMID 21785802 DOI: 10.1039/C1Lc20365G  0.771
2011 Feng Y, Shen J, Streaker ED, Lockwood M, Zhu Z, Low PS, Dimitrov DS. A folate receptor beta-specific human monoclonal antibody recognizes activated macrophage of rheumatoid patients and mediates antibody-dependent cell-mediated cytotoxicity. Arthritis Research & Therapy. 13: R59. PMID 21477314 DOI: 10.1186/Ar3312  0.354
2011 Ferru E, Giger K, Pantaleo A, Campanella E, Grey J, Ritchie K, Vono R, Turrini F, Low PS. Regulation of membrane-cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3. Blood. 117: 5998-6006. PMID 21474668 DOI: 10.1182/Blood-2010-11-317024  0.787
2011 Lu Y, Stinnette TW, Westrick E, Klein PJ, Gehrke MA, Cross VA, Vlahov IR, Low PS, Leamon CP. Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate. Arthritis Research & Therapy. 13: R56. PMID 21463515 DOI: 10.1186/Ar3304  0.53
2010 Kularatne SA, Venkatesh C, Santhapuram HK, Wang K, Vaitilingam B, Henne WA, Low PS. Synthesis and biological analysis of prostate-specific membrane antigen-targeted anticancer prodrugs. Journal of Medicinal Chemistry. 53: 7767-77. PMID 20936874 DOI: 10.1021/Jm100729B  0.803
2010 Adak AK, Leonov AP, Ding N, Thundimadathil J, Kularatne S, Low PS, Wei A. Bishydrazide glycoconjugates for lectin recognition and capture of bacterial pathogens. Bioconjugate Chemistry. 21: 2065-75. PMID 20925370 DOI: 10.1021/Bc100288C  0.776
2010 Franco T, Low PS. Erythrocyte adducin: a structural regulator of the red blood cell membrane. Transfusion Clinique Et Biologique : Journal De La Sociã©Tã© Franã§Aise De Transfusion Sanguine. 17: 87-94. PMID 20655268 DOI: 10.1016/J.Tracli.2010.05.008  0.591
2010 Kodippili GC, Spector J, Kang GE, Liu H, Wickrema A, Ritchie K, Low PS. Analysis of the kinetics of band 3 diffusion in human erythroblasts during assembly of the erythrocyte membrane skeleton. British Journal of Haematology. 150: 592-600. PMID 20553270 DOI: 10.1111/J.1365-2141.2010.08268.X  0.792
2010 Gaind V, Kularatne S, Low PS, Webb KJ. Deep-tissue imaging of intramolecular fluorescence resonance energy-transfer parameters. Optics Letters. 35: 1314-6. PMID 20436553 DOI: 10.1364/Ol.35.001314  0.785
2010 Ayala-López W, Xia W, Varghese B, Low PS. Imaging of atherosclerosis in apoliprotein e knockout mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 768-74. PMID 20395331 DOI: 10.2967/Jnumed.109.071324  0.307
2010 Kularatne SA, Low PS. Targeting of nanoparticles: folate receptor. Methods in Molecular Biology (Clifton, N.J.). 624: 249-65. PMID 20217601 DOI: 10.1007/978-1-60761-609-2_17  0.801
2010 Rotter MA, Chu H, Low PS, Ferrone FA. Band 3 catalyzes sickle hemoglobin polymerization. Biophysical Chemistry. 146: 55-9. PMID 19880238 DOI: 10.1016/J.Bpc.2009.10.004  0.503
2010 Gaind V, Webb KJ, Kularatne SA, Low PS. In vivo Fluorescence Resonance Energy Transfer and Optical Diffusion Tomography Imaging of Targeted Drug Delivery to Tumors Ieee Transactions On Biomedical Engineering. DOI: 10.1364/Biomed.2010.Bsue4  0.789
2010 Reddy JA, Xu L, Dorton R, Bloomfield A, Nelson M, Klein P, Kularatne S, Low P, Leamon C. Abstract 3248: PSMA specific imaging of prostate cancer Cancer Research. 70: 3248-3248. DOI: 10.1158/1538-7445.Am10-3248  0.803
2009 Lewis IA, Campanella ME, Markley JL, Low PS. Role of band 3 in regulating metabolic flux of red blood cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 18515-20. PMID 19846781 DOI: 10.1073/Pnas.0905999106  0.32
2009 Thomas M, Kularatne SA, Qi L, Kleindl P, Leamon CP, Hansen MJ, Low PS. Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues. Annals of the New York Academy of Sciences. 1175: 32-9. PMID 19796075 DOI: 10.1111/J.1749-6632.2009.04977.X  0.811
2009 Vlashi E, Sturgis JE, Thomas M, Low PS. Real time, noninvasive imaging and quantitation of the accumulation of ligand-targeted drugs into receptor-expressing solid tumors. Molecular Pharmaceutics. 6: 1868-75. PMID 19754150 DOI: 10.1021/Mp900158D  0.7
2009 Lu Y, Klein PJ, Westrick E, Xu LC, Santhapuram HK, Bloomfield A, Howard SJ, Vlahov IR, Ellis PR, Low PS, Leamon CP. Strategy to prevent drug-related hypersensitivity in folate-targeted hapten immunotherapy of cancer. The Aaps Journal. 11: 628-38. PMID 19728104 DOI: 10.1208/S12248-009-9139-7  0.52
2009 Anong WA, Franco T, Chu H, Weis TL, Devlin EE, Bodine DM, An X, Mohandas N, Low PS. Adducin forms a bridge between the erythrocyte membrane and its cytoskeleton and regulates membrane cohesion. Blood. 114: 1904-12. PMID 19567882 DOI: 10.1182/Blood-2009-02-203216  0.782
2009 Low PS, Kularatne SA. Folate-targeted therapeutic and imaging agents for cancer. Current Opinion in Chemical Biology. 13: 256-62. PMID 19419901 DOI: 10.1016/J.Cbpa.2009.03.022  0.81
2009 Yi YS, Ayala-López W, Kularatne SA, Low PS. Folate-targeted hapten immunotherapy of adjuvant-induced arthritis: comparison of hapten potencies. Molecular Pharmaceutics. 6: 1228-36. PMID 19374407 DOI: 10.1021/Mp900070B  0.791
2009 Kodippili GC, Spector J, Sullivan C, Kuypers FA, Labotka R, Gallagher PG, Ritchie K, Low PS. Imaging of the diffusion of single band 3 molecules on normal and mutant erythrocytes. Blood. 113: 6237-45. PMID 19369229 DOI: 10.1182/Blood-2009-02-205450  0.798
2009 Kularatne SA, Wang K, Santhapuram HK, Low PS. Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand. Molecular Pharmaceutics. 6: 780-9. PMID 19361233 DOI: 10.1021/Mp900069D  0.812
2009 Kularatne SA, Zhou Z, Yang J, Post CB, Low PS. Design, synthesis, and preclinical evaluation of prostate-specific membrane antigen targeted (99m)Tc-radioimaging agents. Molecular Pharmaceutics. 6: 790-800. PMID 19361232 DOI: 10.1021/Mp9000712  0.799
2009 Xia W, Hilgenbrink AR, Matteson EL, Lockwood MB, Cheng JX, Low PS. A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood. 113: 438-46. PMID 18952896 DOI: 10.1182/Blood-2008-04-150789  0.338
2009 Gaind V, Webb KJ, Kularatne SA, Low PS. In Vivo imaging of targeted drug delivery to tumors based on fluorescence resonance energy transfer and optical diffusion tomography Optics Infobase Conference Papers. DOI: 10.1364/Fio.2009.Ftul3  0.789
2009 Chu H, Hoffman JF, Low PS. Preliminary Identification of ATP Compartment Associated Proteins On Erythrocyte Membrane. Blood. 114: 3019-3019. DOI: 10.1182/Blood.V114.22.3019.3019  0.496
2009 Mattè A, Low PS, Turrini F, Bertoldi M, Campanella ME, Pantaleo A, Siciliano A, De Franceschi L. Peroxiredoxin-2 (Prx2) Membrane Displacement is A New Additional Factor to the Severity of β-Thalassemic Mouse Red Cell Membrane Damage. Blood. 114: 2009-2009. DOI: 10.1182/Blood.V114.22.2009.2009  0.329
2009 Hale JA, Poh S, Kularatne S, Low PS, Ritchie KP. Dynamics Of Folate/Folate Receptor Complexes In KB Cells Observed Through Single Molecule Fluorescence Imaging Biophysical Journal. 96: 282a-283a. DOI: 10.1016/J.Bpj.2008.12.1399  0.803
2008 Campanella ME, Chu H, Wandersee NJ, Peters LL, Mohandas N, Gilligan DM, Low PS. Characterization of glycolytic enzyme interactions with murine erythrocyte membranes in wild-type and membrane protein knockout mice. Blood. 112: 3900-6. PMID 18698006 DOI: 10.1182/Blood-2008-03-146159  0.525
2008 He W, Kularatne SA, Kalli KR, Prendergast FG, Amato RJ, Klee GG, Hartmann LC, Low PS. Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands. International Journal of Cancer. Journal International Du Cancer. 123: 1968-73. PMID 18661519 DOI: 10.1002/Ijc.23717  0.793
2008 Sega EI, Low PS. Tumor detection using folate receptor-targeted imaging agents. Cancer Metastasis Reviews. 27: 655-64. PMID 18523731 DOI: 10.1007/S10555-008-9155-6  0.75
2008 Sega EI, Lu Y, Ringor M, Leamon CP, Low PS. Low-dose radiation potentiates the therapeutic efficacy of folate receptor-targeted hapten therapy. International Journal of Radiation Oncology, Biology, Physics. 71: 559-66. PMID 18411004 DOI: 10.1016/J.Ijrobp.2008.02.010  0.771
2008 Chen H, Kim S, He W, Wang H, Low PS, Park K, Cheng JX. Fast release of lipophilic agents from circulating PEG-PDLLA micelles revealed by in vivo forster resonance energy transfer imaging. Langmuir : the Acs Journal of Surfaces and Colloids. 24: 5213-7. PMID 18257595 DOI: 10.1021/La703570M  0.302
2008 Kalli KR, Oberg AL, Keeney GL, Christianson TJ, Low PS, Knutson KL, Hartmann LC. Folate receptor alpha as a tumor target in epithelial ovarian cancer. Gynecologic Oncology. 108: 619-26. PMID 18222534 DOI: 10.1016/J.Ygyno.2007.11.020  0.328
2008 Zhang K, Wang Q, Xie Y, Mor G, Sega E, Low PS, Huang Y. Receptor-mediated delivery of siRNAs by tethered nucleic acid base-paired interactions. Rna (New York, N.Y.). 14: 577-83. PMID 18218703 DOI: 10.1261/Rna.739308  0.737
2008 Kang JA, Zhou Y, Weis TL, Liu H, Ulaszek J, Satgurunathan N, Zhou L, van Besien K, Crispino J, Verma A, Low PS, Wickrema A. Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblasts. The Journal of Biological Chemistry. 283: 6997-7006. PMID 18174176 DOI: 10.1074/Jbc.M706712200  0.311
2008 Chen H, Yang J, Low PS, Cheng JX. Cholesterol level regulates endosome motility via Rab proteins. Biophysical Journal. 94: 1508-20. PMID 17981910 DOI: 10.1529/Biophysj.106.099366  0.316
2008 Chu H, Breite A, Ciraolo P, Franco RS, Low PS. Characterization of the deoxyhemoglobin binding site on human erythrocyte band 3: implications for O2 regulation of erythrocyte properties. Blood. 111: 932-8. PMID 17942752 DOI: 10.1182/Blood-2007-07-100180  0.522
2008 Low PS, Henne WA, Doorneweerd DD. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Accounts of Chemical Research. 41: 120-9. PMID 17655275 DOI: 10.1021/Ar7000815  0.386
2008 Mohammad T, Amato RJ, Hernandez-McClain J, Messman R, Morgenstern D, Low P, Bevers S. Phase I trial of EC90 (keyhole-limpet hemocyanin fluorescein isothiocyanate conjugate) with GPI-0100 followed by EC 17 (folate- fluorescein isothiocyanate conjugate) in combination with interferon-alpha (ifnα) and interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma (MRCC) Journal of Clinical Oncology. 26: 3081-3081. DOI: 10.1200/Jco.2008.26.15_Suppl.3081  0.348
2008 Varghese B, Vlashi E, Low PS. Folate Receptor Saturation, Recycling, and Release Kinetics in Activated Macrophages Blood. 112: 4655-4655. DOI: 10.1182/Blood.V112.11.4655.4655  0.693
2007 Acharya G, Chang CL, Doorneweerd DD, Vlashi E, Henne WA, Hartmann LC, Low PS, Savran CA. Immunomagnetic diffractometry for detection of diagnostic serum markers. Journal of the American Chemical Society. 129: 15824-9. PMID 18047330 DOI: 10.1021/Ja073094M  0.657
2007 Varghese B, Haase N, Low PS. Depletion of folate-receptor-positive macrophages leads to alleviation of symptoms and prolonged survival in two murine models of systemic lupus erythematosus. Molecular Pharmaceutics. 4: 679-85. PMID 17848087 DOI: 10.1021/Mp0700615  0.318
2007 Lu Y, You F, Vlahov I, Westrick E, Fan M, Low PS, Leamon CP. Folate-targeted dinitrophenyl hapten immunotherapy: effect of linker chemistry on antitumor activity and allergic potential. Molecular Pharmaceutics. 4: 695-706. PMID 17784727 DOI: 10.1021/Mp070050B  0.56
2007 Stefanovic M, Markham NO, Parry EM, Garrett-Beal LJ, Cline AP, Gallagher PG, Low PS, Bodine DM. An 11-amino acid beta-hairpin loop in the cytoplasmic domain of band 3 is responsible for ankyrin binding in mouse erythrocytes. Proceedings of the National Academy of Sciences of the United States of America. 104: 13972-7. PMID 17715300 DOI: 10.1073/Pnas.0706266104  0.599
2007 Yang J, Chen H, Vlahov IR, Cheng JX, Low PS. Characterization of the pH of folate receptor-containing endosomes and the rate of hydrolysis of internalized acid-labile folate-drug conjugates. The Journal of Pharmacology and Experimental Therapeutics. 321: 462-8. PMID 17289839 DOI: 10.1124/Jpet.106.117648  0.308
2007 Messmann R, Amato R, Hernandez-McClain J, Conley B, Rogers H, Lu J, Low P, Bever S, Morgenstern D. A phase II study of FolateImmune (EC90 with GP1–0100 adjuvant followed by EC17) with low dose cytokines interleukin-2 (IL-2) and interferon-α (IFN-α) in patients with refractory or metastatic cancer Journal of Clinical Oncology. 25: 13516-13516. DOI: 10.1200/Jco.2007.25.18_Suppl.13516  0.308
2007 Kodippili GC, Spector J, Sullivan C, Labotka R, Ritchie K, Low PS. Evaluation of the Spectrin Compartment Size in Normal and Diseased Red Blood Cells by Single Particle Tracking. Blood. 110: 143-143. DOI: 10.1182/Blood.V110.11.143.143  0.798
2007 Chu H, Breite A, Ciraolo P, Franco RS, Low PS. Localization and Functional Characterization of the Deoxyhemoglobin Binding Site on Human Erythrocyte Band 3. Blood. 110: 140-140. DOI: 10.1182/blood.v110.11.140.140  0.463
2007 Low P, He W, Vlashi E, Cheng J, Kennedy M. Optical Imaging of Cancer Cells in vivo with Folate Receptor-Targeted Fluorescent Dyes Microscopy and Microanalysis. 13. DOI: 10.1017/S1431927607073928  0.684
2006 Lu Y, Xu LC, Parker N, Westrick E, Reddy JA, Vetzel M, Low PS, Leamon CP. Preclinical pharmacokinetics, tissue distribution, and antitumor activity of a folate-hapten conjugate-targeted immunotherapy in hapten-immunized mice. Molecular Cancer Therapeutics. 5: 3258-67. PMID 17172429 DOI: 10.1158/1535-7163.Mct-06-0439  0.565
2006 Yang J, Chen H, Vlahov IR, Cheng JX, Low PS. Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging. Proceedings of the National Academy of Sciences of the United States of America. 103: 13872-7. PMID 16950881 DOI: 10.1073/Pnas.0601455103  0.332
2006 Henne WA, Doorneweerd DD, Hilgenbrink AR, Kularatne SA, Low PS. Synthesis and activity of a folate peptide camptothecin prodrug. Bioorganic & Medicinal Chemistry Letters. 16: 5350-5. PMID 16901694 DOI: 10.1016/J.Bmcl.2006.07.076  0.794
2006 Chu H, Low PS. Mapping of glycolytic enzyme-binding sites on human erythrocyte band 3. The Biochemical Journal. 400: 143-51. PMID 16836485 DOI: 10.1042/Bj20060792  0.515
2006 Anong WA, Weis TL, Low PS. Rate of rupture and reattachment of the band 3-ankyrin bridge on the human erythrocyte membrane. The Journal of Biological Chemistry. 281: 22360-6. PMID 16762928 DOI: 10.1074/Jbc.M513839200  0.788
2006 Paulos CM, Varghese B, Widmer WR, Breur GJ, Vlashi E, Low PS. Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis. Arthritis Research & Therapy. 8: R77. PMID 16646988 DOI: 10.1186/Ar1944  0.773
2005 Wandersee NJ, Punzalan RC, Rettig MP, Kennedy MD, Pajewski NM, Sabina RL, Paul Scott J, Low PS, Hillery CA. Erythrocyte adhesion is modified by alterations in cellular tonicity and volume. British Journal of Haematology. 131: 366-77. PMID 16225657 DOI: 10.1111/J.1365-2141.2005.05767.X  0.702
2005 Hilgenbrink AR, Low PS. Folate receptor-mediated drug targeting: from therapeutics to diagnostics. Journal of Pharmaceutical Sciences. 94: 2135-46. PMID 16136558 DOI: 10.1002/Jps.20457  0.398
2005 Perrotta S, Borriello A, Scaloni A, De Franceschi L, Brunati AM, Turrini F, Nigro V, Miraglia Del Giudice E, Nobili B, Conte ML, Rossi F, Iolascon A, Donella-Deana A, Zappia V, Poggi V, ... ... Low P, et al. The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: Implications for band 3 function Blood. 106: 4359-4365. PMID 16118313 DOI: 10.1182/Blood-2005-07-2806  0.794
2005 Bordin L, Ion-Popa F, Brunati AM, Clari G, Low PS. Effector-induced Syk-mediated phosphorylation in human erythrocytes. Biochimica Et Biophysica Acta. 1745: 20-8. PMID 16085052 DOI: 10.1016/J.Bbamcr.2004.12.010  0.303
2005 Milstein AB, Kennedy MD, Low PS, Bouman CA, Webb KJ. Statistical approach for detection and localization of a fluorescing mouse tumor in Intralipid. Applied Optics. 44: 2300-10. PMID 15861835 DOI: 10.1364/Ao.44.002300  0.56
2005 Lu Y, Sega E, Low PS. Folate receptor-targeted immunotherapy: induction of humoral and cellular immunity against hapten-decorated cancer cells. International Journal of Cancer. Journal International Du Cancer. 116: 710-9. PMID 15828051 DOI: 10.1002/Ijc.21126  0.781
2005 Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, Leamon CP. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Analytical Biochemistry. 338: 284-93. PMID 15745749 DOI: 10.1016/J.Ab.2004.12.026  0.617
2005 Antohe F, Radulescu L, Puchianu E, Kennedy MD, Low PS, Simionescu M. Increased uptake of folate conjugates by activated macrophages in experimental hyperlipemia. Cell and Tissue Research. 320: 277-85. PMID 15714274 DOI: 10.1007/S00441-004-1071-7  0.586
2005 Campanella ME, Chu H, Low PS. Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane. Proceedings of the National Academy of Sciences of the United States of America. 102: 2402-7. PMID 15701694 DOI: 10.1073/Pnas.0409741102  0.537
2005 Anong WA, Mohandas N, An X, Bodine DM, Markham NO, Gallagher PG, Low PS. Adducin Forms a Bridge between the Spectrin-Actin Junctional Complex and Band 3. Blood. 106: 808-808. DOI: 10.1182/Blood.V106.11.808.808  0.791
2005 Chu H, Low PS. Mapping of the Glycolytic Enzyme Binding Sites on Human Erythrocyte Membrane Band 3. Blood. 106: 1668-1668. DOI: 10.1182/Blood.V106.11.1668.1668  0.52
2005 Markham NO, Parry EM, Stefanovic M, Gallagher PG, Low PS, Bodine DM. Genetic Evidence That an 11 Amino Acid β-Hairpin Loop in the Cytoplasmic Domain of Band 3 Is Responsible for at Least 50% of Ankyrin Binding in Mouse Erythrocytes. Blood. 106: 1659-1659. DOI: 10.1182/Blood.V106.11.1659.1659  0.598
2004 Paulos CM, Reddy JA, Leamon CP, Turk MJ, Low PS. Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery. Molecular Pharmacology. 66: 1406-14. PMID 15371560 DOI: 10.1124/Mol.104.003723  0.77
2004 Turk MJ, Waters DJ, Low PS. Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma. Cancer Letters. 213: 165-72. PMID 15327831 DOI: 10.1016/J.Canlet.2003.12.028  0.664
2004 Stephenson SM, Low PS, Lee RJ. Folate receptor-mediated targeting of liposomal drugs to cancer cells. Methods in Enzymology. 387: 33-50. PMID 15172156 DOI: 10.1016/S0076-6879(04)87003-4  0.365
2004 Sandoval RM, Kennedy MD, Low PS, Molitoris BA. Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy. American Journal of Physiology. Cell Physiology. 287: C517-26. PMID 15102609 DOI: 10.1152/Ajpcell.00006.2004  0.602
2004 Paulos CM, Turk MJ, Breur GJ, Low PS. Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Advanced Drug Delivery Reviews. 56: 1205-17. PMID 15094216 DOI: 10.1016/J.Addr.2004.01.012  0.74
2004 Lu Y, Sega E, Leamon CP, Low PS. Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential. Advanced Drug Delivery Reviews. 56: 1161-76. PMID 15094213 DOI: 10.1016/J.Addr.2004.01.009  0.792
2004 Low PS, Antony AC. Folate receptor-targeted drugs for cancer and inflammatory diseases. Advanced Drug Delivery Reviews. 56: 1055-8. PMID 15094205 DOI: 10.1016/J.Addr.2004.02.003  0.321
2004 Weber RE, Voelter W, Fago A, Echner H, Campanella E, Low PS. Modulation of red cell glycolysis: interactions between vertebrate hemoglobins and cytoplasmic domains of band 3 red cell membrane proteins. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 287: R454-64. PMID 15087282 DOI: 10.1152/Ajpregu.00060.2004  0.357
2004 Perrotta S, Adriana B, De Franceschi L, Nobili B, Iolascon A, Brunati AM, Rossi F, Turrini F, Ragione FD, Low P, Mohandas N. New Insights into the Function of N-Terminal 11 Amino Acids of Band 3 from Structural and Functional Study of a Naturally Occuring Band 3 Variant. Blood. 104: 577-577. DOI: 10.1182/Blood.V104.11.577.577  0.353
2004 Greipp P, Cascino G, Kimlinger T, Rajkumar V, Prendergast FG, Fonseca R, Bergsagel PL, Low PS, Greipp PR. Plasma Cell Folate Receptor Overexpression Differentiates Multiple Myeloma from Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma. Blood. 104: 3649-3649. DOI: 10.1182/Blood.V104.11.3649.3649  0.374
2004 Wandersee NJ, Punzalan RC, Sillah NM, Rettig MP, Kennedy MD, Scott JP, Low PS, Hillery CA. Modulation of Erythrocyte Adhesion by Changes in Cellular Tonicity and Volume. Blood. 104: 1577-1577. DOI: 10.1182/Blood.V104.11.1577.1577  0.706
2004 Low PS, Campanella EM, Anong WA, Wandersee NJ, Hillary CA, Chishti A. Characterization of Glycolytic Enzyme Complexes on Murine Erythrocyte Membranes. Blood. 104: 1571-1571. DOI: 10.1182/Blood.V104.11.1571.1571  0.791
2003 Kennedy MD, Jallad KN, Thompson DH, Ben-Amotz D, Low PS. Optical imaging of metastatic tumors using a folate-targeted fluorescent probe. Journal of Biomedical Optics. 8: 636-41. PMID 14563201 DOI: 10.1117/1.1609453  0.6
2003 Lu Y, Low PS. Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects. Journal of Controlled Release : Official Journal of the Controlled Release Society. 91: 17-29. PMID 12932634 DOI: 10.1016/S0168-3659(03)00215-3  0.561
2003 Kennedy MD, Jallad KN, Lu J, Low PS, Ben-Amotz D. Evaluation of folate conjugate uptake and transport by the choroid plexus of mice. Pharmaceutical Research. 20: 714-9. PMID 12751625 DOI: 10.1023/A:1023421232689  0.576
2003 Lu Y, Low PS. Targeted immunotherapy of cancer: development of antibody-induced cellular immunity. The Journal of Pharmacy and Pharmacology. 55: 163-7. PMID 12635651 DOI: 10.1211/002235702540  0.506
2003 Gallagher PG, Chang SH, Rettig MP, Neely JE, Hillery CA, Smith BD, Low PS. Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood. 101: 4625-7. PMID 12560240 DOI: 10.1182/Blood-2001-12-0329  0.67
2003 Chang SH, Low PS. Identification of a critical ankyrin-binding loop on the cytoplasmic domain of erythrocyte membrane band 3 by crystal structure analysis and site-directed mutagenesis. The Journal of Biological Chemistry. 278: 6879-84. PMID 12482869 DOI: 10.1074/Jbc.M211137200  0.549
2002 de Jong K, Rettig MP, Low PS, Kuypers FA. Protein kinase C activation induces phosphatidylserine exposure on red blood cells. Biochemistry. 41: 12562-7. PMID 12369848 DOI: 10.1021/Bi025882O  0.558
2002 Lu Y, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Advanced Drug Delivery Reviews. 54: 675-93. PMID 12204598 DOI: 10.1016/S0169-409X(02)00042-X  0.592
2002 Turk MJ, Breur GJ, Widmer WR, Paulos CM, Xu LC, Grote LA, Low PS. Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis. Arthritis and Rheumatism. 46: 1947-55. PMID 12124880 DOI: 10.1002/Art.10405  0.733
2002 Trump DP, Mathias CJ, Yang Z, Low PS, Marmion M, Green MA. Synthesis and evaluation of 99mTc(CO)(3)-DTPA-folate as a folate-receptor-targeted radiopharmaceutical. Nuclear Medicine and Biology. 29: 569-73. PMID 12088727 DOI: 10.1016/S0969-8051(02)00310-4  0.379
2002 Matsumoto TK, Ellsmore AJ, Cessna SG, Low PS, Pardo JM, Bressan RA, Hasegawa PM. An osmotically induced cytosolic Ca2+ transient activates calcineurin signaling to mediate ion homeostasis and salt tolerance of Saccharomyces cerevisiae. The Journal of Biological Chemistry. 277: 33075-80. PMID 12084723 DOI: 10.1074/Jbc.M205037200  0.749
2002 Khanna R, Chang SH, Andrabi S, Azam M, Kim A, Rivera A, Brugnara C, Low PS, Liu SC, Chishti AH. Headpiece domain of dematin is required for the stability of the erythrocyte membrane. Proceedings of the National Academy of Sciences of the United States of America. 99: 6637-42. PMID 12011427 DOI: 10.1073/Pnas.052155999  0.55
2002 Lee JW, Lu JY, Low PS, Fuchs PL. Synthesis and evaluation of taxol-folic acid conjugates as targeted antineoplastics. Bioorganic & Medicinal Chemistry. 10: 2397-414. PMID 11983537 DOI: 10.1016/S0968-0896(02)00019-6  0.31
2002 Lu Y, Low PS. Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors. Cancer Immunology, Immunotherapy : Cii. 51: 153-62. PMID 11941454 DOI: 10.1007/S00262-002-0266-6  0.595
2002 Turk MJ, Reddy JA, Chmielewski JA, Low PS. Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs. Biochimica Et Biophysica Acta. 1559: 56-68. PMID 11825588 DOI: 10.1016/S0005-2736(01)00441-2  0.599
2001 Cessna SG, Low PS. Activation of the oxidative burst in aequorin-transformed Nicotiana tabacum cells is mediated by protein kinase- and anion channel-dependent release of Ca2+ from internal stores. Planta. 214: 126-34. PMID 11762162 DOI: 10.1007/S004250100596  0.747
2001 Rettig MP, Orendorff CJ, Campanella E, Low PS. Effect of pH on the self-association of erythrocyte band 3 in situ. Biochimica Et Biophysica Acta. 1515: 72-81. PMID 11597354 DOI: 10.1016/S0005-2736(01)00397-2  0.561
2001 Van Dort HM, Knowles DW, Chasis JA, Lee G, Mohandas N, Low PS. Analysis of integral membrane protein contributions to the deformability and stability of the human erythrocyte membrane. The Journal of Biological Chemistry. 276: 46968-74. PMID 11595743 DOI: 10.1074/Jbc.M107855200  0.335
2001 Cessna SG, Messerli MA, Robinson KR, Low PS. Measurement of stress-induced Ca(2+) pulses in single aequorin-transformed tobacco cells. Cell Calcium. 30: 151-6. PMID 11508994 DOI: 10.1054/Ceca.2001.0226  0.759
2001 Reddy JA, Clapp DW, Low PS. Retargeting of viral vectors to the folate receptor endocytic pathway. Journal of Controlled Release : Official Journal of the Controlled Release Society. 74: 77-82. PMID 11489485 DOI: 10.1016/S0168-3659(01)00316-9  0.325
2001 Taylor AT, Kim J, Low PS. Involvement of mitogen-activated protein kinase activation in the signal-transduction pathways of the soya bean oxidative burst. The Biochemical Journal. 355: 795-803. PMID 11311144 DOI: 10.1042/Bj3550795  0.412
2001 Chang SH, Low PS. Regulation of the glycophorin C-protein 4.1 membrane-to-skeleton bridge and evaluation of its contribution to erythrocyte membrane stability. The Journal of Biological Chemistry. 276: 22223-30. PMID 11294862 DOI: 10.1074/Jbc.M100604200  0.554
2001 Leamon CP, Low PS. Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug Discovery Today. 6: 44-51. PMID 11165172 DOI: 10.1016/S1359-6446(00)01594-4  0.364
2001 Cessna SG, Low PS. An apoplastic Ca2+ sensor regulates internal Ca2+ release in aequorin-transformed tobacco cells. The Journal of Biological Chemistry. 276: 10655-62. PMID 11139570 DOI: 10.1074/Jbc.M006989200  0.746
2000 Lee RJ, Low PS. Folate as a targeting device for proteins utilizing folate receptor-mediated endocytosis. Methods in Molecular Medicine. 25: 69-76. PMID 21318841 DOI: 10.1385/1-59259-075-6:69  0.303
2000 Cessna SG, Sears VE, Dickman MB, Low PS. Oxalic acid, a pathogenicity factor for Sclerotinia sclerotiorum, suppresses the oxidative burst of the host plant. The Plant Cell. 12: 2191-200. PMID 11090218 DOI: 10.1105/Tpc.12.11.2191  0.755
2000 Chandra S, Cessna SG, Yahraus T, Devine R, Low PS. Homologous and heterologous desensitization and synergy in pathways leading to the soybean oxidative burst. Planta. 211: 736-42. PMID 11089688 DOI: 10.1007/S004250000344  0.749
2000 Magowan C, Nunomura W, Waller KL, Yeung J, Liang J, Van Dort H, Low PS, Coppel RL, Mohandas N. Plasmodium falciparum histidine-rich protein 1 associates with the band 3 binding domain of ankyrin in the infected red cell membrane. Biochimica Et Biophysica Acta. 1502: 461-70. PMID 11068188 DOI: 10.1016/S0925-4439(00)00069-7  0.34
2000 Mathias CJ, Hubers D, Low PS, Green MA. Synthesis of [(99m)Tc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical. Bioconjugate Chemistry. 11: 253-7. PMID 10725102 DOI: 10.1021/Bc9901447  0.321
2000 Zhang D, Kiyatkin A, Bolin JT, Low PS. Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3 Blood. 96: 2925-2933. DOI: 10.1182/Blood.V96.9.2925.H8002925_2925_2933  0.343
2000 Low PS, Zhang D, Bolin JT, Chang S, Andrews D, Yang L, Rettig M. Structure, function, and regulation of erythrocyte band 3 (AE1) Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology. 126: S63. DOI: 10.1016/S0305-0491(00)80125-X  0.547
1999 Lu JY, Lowe DA, Kennedy MD, Low PS. Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug. Journal of Drug Targeting. 7: 43-53. PMID 10614814 DOI: 10.3109/10611869909085491  0.63
1999 Reddy JA, Dean D, Kennedy MD, Low PS. Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy. Journal of Pharmaceutical Sciences. 88: 1112-8. PMID 10564057 DOI: 10.1021/Js990169E  0.581
1999 Bruce LJ, Ring SM, Ridgwell K, Reardon DM, Seymour CA, Van Dort HM, Low PS, Tanner MJ. South-east asian ovalocytic (SAO) erythrocytes have a cold sensitive cation leak: implications for in vitro studies on stored SAO red cells. Biochimica Et Biophysica Acta. 1416: 258-70. PMID 9889381 DOI: 10.1016/S0005-2736(98)00231-4  0.329
1999 Holladay SR, Yang Z, Kennedy MD, Leamon CP, Lee RJ, Jayamani M, Mason T, Low PS. Riboflavin-mediated delivery of a macromolecule into cultured human cells. Biochimica Et Biophysica Acta. 1426: 195-204. PMID 9878734 DOI: 10.1016/S0304-4165(98)00147-0  0.607
1999 Rettig MP, Low PS, Gimm JA, Mohandas N, Wang J, Christian JA. Evaluation of biochemical changes during in vivo erythrocyte senescence in the dog. Blood. 93: 376-84. PMID 9864184 DOI: 10.1182/Blood.V93.1.376.401K41_376_384  0.604
1999 Reddy JA, Haneline LS, Srour EF, Antony AC, Clapp DW, Low PS. Expression and Functional Characterization of the β-Isoform of the Folate Receptor on CD34+ Cells Blood. 93: 3940-3948. DOI: 10.1182/Blood.V93.11.3940.411K09_3940_3948  0.35
1998 Cessna SG, Chandra S, Low PS. Hypo-osmotic shock of tobacco cells stimulates Ca2+ fluxes deriving first from external and then internal Ca2+ stores. The Journal of Biological Chemistry. 273: 27286-91. PMID 9765253 DOI: 10.1074/Jbc.273.42.27286  0.742
1998 Lee RJ, Wang S, Turk MJ, Low PS. The effects of pH and intraliposomal buffer strength on the rate of liposome content release and intracellular drug delivery. Bioscience Reports. 18: 69-78. PMID 9743475 DOI: 10.1023/A:1020132226113  0.611
1998 Wang S, Low PS. Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. Journal of Controlled Release : Official Journal of the Controlled Release Society. 53: 39-48. PMID 9741912 DOI: 10.1016/S0168-3659(97)00236-8  0.411
1998 Van Dort HM, Moriyama R, Low PS. Effect of band 3 subunit equilibrium on the kinetics and affinity of ankyrin binding to erythrocyte membrane vesicles. The Journal of Biological Chemistry. 273: 14819-26. PMID 9614083 DOI: 10.1074/Jbc.273.24.14819  0.344
1998 Workman RF, Low PS. Biochemical analysis of potential sites for protein 4.1-mediated anchoring of the spectrin-actin skeleton to the erythrocyte membrane. The Journal of Biological Chemistry. 273: 6171-6. PMID 9497338 DOI: 10.1074/Jbc.273.11.6171  0.339
1998 Reddy JA, Low PS. Folate-Mediated Targeting of Therapeutic and Imaging Agents to Cancers Critical Reviews™ in Therapeutic Drug Carrier Systems. 15: 41. DOI: 10.1615/Critrevtherdrugcarriersyst.V15.I6.20  0.397
1998 Christian JA, Wang J, Kiyatkina N, Rettig M, Low PS. How Old Are Dense Red Blood Cells? The Dog's Tale Blood. 92: 2590-2591. DOI: 10.1182/Blood.V92.7.2590.2590_2590_2591  0.57
1998 Rui Y, Wang S, Low PS, Thompson DH. Diplasmenylcholine-folate liposomes: An efficient vehicle for intracellular drug delivery Journal of the American Chemical Society. 120: 11213-11218. DOI: 10.1021/Ja9742949  0.319
1997 Wang S, Luo J, Lantrip DA, Waters DJ, Mathias CJ, Green MA, Fuchs PL, Low PS. Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical. Bioconjugate Chemistry. 8: 673-9. PMID 9327130 DOI: 10.1021/Bc9701297  0.38
1997 Lee RJ, Low PS. Folate-Targeted Liposomes for Drug Delivery Journal of Liposome Research. 7: 455-466. DOI: 10.3109/08982109709035512  0.398
1996 Wang S, Lee RJ, Mathias CJ, Green MA, Low PS. Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging. Bioconjugate Chemistry. 7: 56-62. PMID 8741991 DOI: 10.1021/Bc9500709  0.341
1996 Vogel K, Wang S, Lee RJ, Chmielewski J, Low PS. Peptide-mediated release of folate-targeted liposome contents from endosomal compartments Journal of the American Chemical Society. 118: 1581-1586. DOI: 10.1021/Ja952725M  0.316
1995 Lee RJ, Low PS. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochimica Et Biophysica Acta. 1233: 134-44. PMID 7865538 DOI: 10.1016/0005-2736(94)00235-H  0.403
1995 Wang S, Lee RJ, Cauchon G, Gorenstein DG, Low PS. Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. Proceedings of the National Academy of Sciences of the United States of America. 92: 3318-22. PMID 7724560 DOI: 10.1073/Pnas.92.8.3318  0.345
1995 Wang CC, Moriyama R, Lombardo CR, Low PS. Partial characterization of the cytoplasmic domain of human kidney band 3. The Journal of Biological Chemistry. 270: 17892-7. PMID 7629093 DOI: 10.1074/Jbc.270.30.17892  0.301
1995 Low PS, Kiyatkin A, Li Q, Harrison ML. Control of erythrocyte metabolism by redox-regulated tyrosine phosphatases and kinases Protoplasma. 184: 196-202. DOI: 10.1007/Bf01276920  0.308
1994 Leamon CP, Low PS. Selective targeting of malignant cells with cytotoxin-folate conjugates. Journal of Drug Targeting. 2: 101-12. PMID 8069588 DOI: 10.3109/10611869409015898  0.4
1994 Lombardo CR, Low PS. Calmodulin modulates protein 4.1 binding to human erythrocyte membranes. Biochimica Et Biophysica Acta. 1196: 139-44. PMID 7841177 DOI: 10.1016/0005-2736(94)00233-9  0.312
1993 Legendre L, Rueter S, Heinstein PF, Low PS. Characterization of the Oligogalacturonide-Induced Oxidative Burst in Cultured Soybean (Glycine max) Cells. Plant Physiology. 102: 233-240. PMID 12231814 DOI: 10.1104/Pp.102.1.233  0.306
1993 Leamon CP, Low PS. Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells. The Biochemical Journal. 291: 855-60. PMID 8387781 DOI: 10.1042/Bj2910855  0.388
1993 Turrini F, Mannu F, Arese P, Yuan J, Low P. Characterization of the autologous antibodies that opsonize erythrocytes with clustered integral membrane proteins Blood. 81: 3146-3152. DOI: 10.1182/Blood.V81.11.3146.3146  0.311
1992 Horn MA, Heinstein PF, Low PS. Characterization of parameters influencing receptor-mediated endocytosis in cultured soybean cells. Plant Physiology. 98: 673-9. PMID 16668694 DOI: 10.1104/Pp.98.2.673  0.312
1992 Low PS. Role of hemoglobin denaturation and band 3 clustering in initiating red cell removal. Advances in Experimental Medicine and Biology. 307: 173-83. PMID 1805586 DOI: 10.1007/978-1-4684-5985-2_16  0.357
1992 Wang CC, Badylak JA, Lux SE, Moriyama R, Dixon JE, Low PS. Expression, purification, and characterization of the functional dimeric cytoplasmic domain of human erythrocyte band 3 in Escherichia coli. Protein Science : a Publication of the Protein Society. 1: 1206-14. PMID 1304397 DOI: 10.1002/Pro.5560010913  0.347
1992 Harrison M, Isaacson C, Rathinavelu P, Low PS. Resealing of protein tyrosine kinase substrates into human erythrocytes by rapid freezing and thawing in liquid nitrogen. Advances in Experimental Medicine and Biology. 326: 111-7. PMID 1295296 DOI: 10.1007/978-1-4615-3030-5_13  0.315
1992 Yuan J, Kannan R, Shinar E, Rachmilewitz E, Low P. Isolation, characterization, and immunoprecipitation studies of immune complexes from membranes of beta-thalassemic erythrocytes Blood. 79: 3007-3013. DOI: 10.1182/Blood.V79.11.3007.3007  0.338
1991 Leamon CP, Low PS. Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proceedings of the National Academy of Sciences of the United States of America. 88: 5572-6. PMID 2062838 DOI: 10.1073/Pnas.88.13.5572  0.337
1991 Kannan R, Yuan J, Low PS. Isolation and partial characterization of antibody- and globin-enriched complexes from membranes of dense human erythrocytes. The Biochemical Journal. 278: 57-62. PMID 1883341 DOI: 10.1042/Bj2780057  0.326
1991 Low P, Willardson B, Mohandas N, Rossi M, Shohet S. Contribution of the band 3-ankyrin interaction to erythrocyte membrane mechanical stability Blood. 77: 1581-1586. DOI: 10.1182/Blood.V77.7.1581.Bloodjournal7771581  0.333
1989 Horn MA, Heinstein PF, Low PS. Receptor-Mediated Endocytosis in Plant Cells. The Plant Cell. 1: 1003-1009. PMID 12359884 DOI: 10.1105/Tpc.1.10.1003  0.327
1988 Verlander JW, Madsen KM, Low PS, Allen DP, Tisher CC. Immunocytochemical localization of band 3 protein in the rat collecting duct. The American Journal of Physiology. 255: F115-25. PMID 3394806 DOI: 10.1152/Ajprenal.1988.255.1.F115  0.35
1988 Gruber HJ, Low PS. Interaction of amphiphiles with integral membrane proteins. I. Structural destabilization of the anion transport protein of the erythrocyte membrane by fatty acids, fatty alcohols, and fatty amines. Biochimica Et Biophysica Acta. 944: 414-24. PMID 3179297 DOI: 10.1016/0005-2736(88)90512-3  0.311
1988 Allen DP, Low PS, Dola A, Maisel H. Band 3 and ankyrin homologues are present in eye lens: evidence for all major erythrocyte membrane components in same non-erythroid cell. Biochemical and Biophysical Research Communications. 149: 266-75. PMID 2961337 DOI: 10.1016/0006-291X(87)91634-2  0.357
1987 Apostol I, Low PS, Heinstein P, Stipanovic RD, Altman DW. Inhibition of elicitor-induced phytoalexin formation in cotton and soybean cells by citrate. Plant Physiology. 84: 1276-80. PMID 16665597 DOI: 10.1104/Pp.84.4.1276  0.321
1987 Waugh SM, Walder JA, Low PS. Partial characterization of the copolymerization reaction of erythrocyte membrane band 3 with hemichromes. Biochemistry. 26: 1777-83. PMID 3593688 DOI: 10.1021/Bi00380A041  0.305
1986 Low PS, Heinstein PF. Elicitor stimulation of the defense response in cultured plant cells monitored by fluorescent dyes. Archives of Biochemistry and Biophysics. 249: 472-9. PMID 3753013 DOI: 10.1016/0003-9861(86)90024-X  0.31
1986 Waugh SM, Willardson BM, Kannan R, Labotka RJ, Low PS. Heinz bodies induce clustering of band 3, glycophorin, and ankyrin in sickle cell erythrocytes Journal of Clinical Investigation. 78: 1155-1160. PMID 2945831 DOI: 10.1172/Jci112696  0.336
1986 Low PS. Structure and function of the cytoplasmic domain of band 3: center of erythrocyte membrane-peripheral protein interactions. Biochimica Et Biophysica Acta. 864: 145-67. PMID 2943319 DOI: 10.1016/0304-4157(86)90009-2  0.307
1985 Waugh SM, Low PS. Hemichrome binding to band 3: nucleation of Heinz bodies on the erythrocyte membrane. Biochemistry. 24: 34-9. PMID 3994972 DOI: 10.1021/Bi00322A006  0.335
1985 Low PS, Waugh SM, Zinke K, Drenckhahn D. The role of hemoglobin denaturation and band 3 clustering in red blood cell aging. Science (New York, N.Y.). 227: 531-3. PMID 2578228 DOI: 10.1126/Science.2578228  0.312
1982 Davio SR, Low PS. Characterization of the calorimetric C transition of the human erythrocyte membrane. Biochemistry. 21: 3585-93. PMID 7115687 DOI: 10.1021/Bi00258A009  0.318
1979 Low PS, Brandts JF. The interaction of adenine nucleotides with the red cell membrane: a calorimetric study. Archives of Biochemistry and Biophysics. 190: 640-6. PMID 718169 DOI: 10.1016/0003-9861(78)90321-1  0.339
1978 Snow JW, Brandts JF, Low PS. The effects of anion transport inhibitors on structural transitions in erythrocyte membranes. Biochimica Et Biophysica Acta. 512: 579-91. PMID 708734 DOI: 10.1016/0005-2736(78)90167-0  0.317
1978 Low PS, Hoffmann KH, Swezey R, Somero GN. Protein water binding ability correlates with cellular osmolarity. Experientia. 34: 314-5. PMID 631253 DOI: 10.1007/Bf01923006  0.749
1977 Somero GN, Neubauer M, Low PS. Neutral salt effects on the velocity and activation volume of the lactate dehydrogenase reaction: evidence for enzyme hydration changes during catalysis. Archives of Biochemistry and Biophysics. 181: 438-46. PMID 900931 DOI: 10.1016/0003-9861(77)90249-1  0.505
1977 Somero GN, Low PS. Enzyme hydration may explain catalytic efficiency differences among lactate dehydrogenase homologues. Nature. 266: 276-8. PMID 846575 DOI: 10.1038/266276A0  0.509
1977 Somero GN, Low PS. Eurytolerant Proteins: Mechanisms for Extending the Environmental Tolerance Range of Enzyme-Ligand Interactions The American Naturalist. 111: 527-538. DOI: 10.1086/283182  0.534
1976 Low PS, Somero GN. Adaptation of muscle pyruvate kinases to environmental temperatures and pressures. The Journal of Experimental Zoology. 198: 1-11. PMID 824400 DOI: 10.1002/Jez.1401980102  0.49
1976 Somero GN, Low PS. Temperature: a "shaping force' in protein evolution. Biochemical Society Symposium. 33-42. PMID 788719  0.449
1975 Low PS, Somero GN. Pressure effects on enzyme structure and function in vitro and under simulated in vivo conditions. Comparative Biochemistry and Physiology. B, Comparative Biochemistry. 52: 67-74. PMID 1183178 DOI: 10.1016/0305-0491(75)90117-0  0.497
1975 Low PS, Somero GN. Protein hydration changes during catalysis: a new mechanism of enzymic rate-enhancement and ion activation/inhibition of catalysis. Proceedings of the National Academy of Sciences of the United States of America. 72: 3305-9. PMID 1059113 DOI: 10.1073/Pnas.72.9.3305  0.505
1975 Low PS, Somero GN. Activation volumes in enzymic catalysis: their sources and modification by low-molecular-weight solutes. Proceedings of the National Academy of Sciences of the United States of America. 72: 3014-8. PMID 1059089 DOI: 10.1073/Pnas.72.8.3014  0.496
1974 Low PS, Somero GN. Temperature adaptation of enzymes: a proposed molecular basis for the different catalytic efficiencies of enzymes from ectotherms and endotherms. Comparative Biochemistry and Physiology. B, Comparative Biochemistry. 49: 307-12. PMID 4420155 DOI: 10.1016/0305-0491(74)90165-5  0.489
1973 Low PS, Bada JL, Somero GN. Temperature adaptation of enzymes: roles of the free energy, the enthalpy, and the entropy of activation. Proceedings of the National Academy of Sciences of the United States of America. 70: 430-2. PMID 4510286 DOI: 10.1073/Pnas.70.2.430  0.491
Show low-probability matches.